Chuck Grassley opened the hearing saying that Americans are “sick and tired of the blame game.”
in a capital where they typically win their lobbying battles.
We cannot allow anyone to hide behind the current complexities to shield the true cost of drugs,’’ Grassley said. Bourla and other executives said they favored “value-based’’ reimbursement, a reform that is beginning to get more attention. It works like this: Pfizer would get paid based on the number of strokes it prevented or the number of cancer patients in full remission, “rather than the number of pills we sell,’’ Bourla said.
“Part D patients’ out-of-pocket costs have significantly increased. Some would blame that solely on high drug prices, and we agree that price should certainly be part of the discussion,’’ he told the committee in his written remarks. “But it’s also important to acknowledge that science has enabled us to advance the standard of care far beyond what was possible when the Part D benefit was designed.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Sen. Grassley says probe of 'secretive' drug industry pricing won't stop with drugmakersSenate Finance Committee Chairman Chuck Grassley said there needs to be more transparency into how drug prices are set, a system which he said seems to be 'a great deal of secrecy.'
Read more »
Pharmaceutical Industry CEOs Face Senate Hearing on Drug PricesExecutives for some of the biggest drug companies will visit Capitol Hill on Tuesday to face tough questions in a Senate hearing on the rising cost of medicines.
Read more »
Mexican drug lord Joaquin 'El Chapo' Guzmán's sons indicted on drug chargesThe United States has charged two sons of drug lord Joaquin 'El Chapo' Guzmán Loera with conspiracy to distribute drugs to be imported into the country, the Justice Department announced Thursday.
Read more »
U.S. top court rejects Maryland bid to revive drug price-gouging lawThe U.S. Supreme Court on Tuesday rejected Maryland's bid to revive a law a...
Read more »
'Wacky' drug price system keeps costs high for patients paying for prescriptions, FDA Chief saysRebates are a favorite target of pharmaceutical companies, who say pharmaceutical benefit managers extract huge discounts but keep them for themselves instead of sharing the savings with patients.
Read more »
GOP maneuver will block Yemen bill from getting Senate voteA House-passed bill to halt U.S. involvement in Yemen’s deadly civil war will not get a vote in the Senate
Read more »